May 3, 2006
Bausch & Lomb Says Initial Fusarium Findings Require More Investigation
Posted at May 3, 2006 8:41 AM in Drug Products
.
In reaction to the CDC's initial report on the fusarium fungus linked to Bausch & Lomb's ReNu, the company has stated that the report requires further investigation. Now, we don't know if this public relations obfuscation or the data reported thus far really requires further review. We do know that this fungus can cause blindness and/or serious eye damage if it's not treated in a timely fashion.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/34 .